Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509288
Status:
COMPLETED
Last Update Posted:
2012-12-28
First Post:
2007-07-30
Brief Title:
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-30
First Submit QC Date:
July 30 2007
Study First Post Date:
2007-07-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-12-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-12-27
Last Update Post Date:
2012-12-28
Last Update Post Date Type:
ESTIMATED